1. Home
  2. MAIN vs APLS Comparison

MAIN vs APLS Comparison

Compare MAIN & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIN
  • APLS
  • Stock Information
  • Founded
  • MAIN 2007
  • APLS 2009
  • Country
  • MAIN United States
  • APLS United States
  • Employees
  • MAIN N/A
  • APLS N/A
  • Industry
  • MAIN Finance/Investors Services
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MAIN Finance
  • APLS Health Care
  • Exchange
  • MAIN Nasdaq
  • APLS Nasdaq
  • Market Cap
  • MAIN 4.5B
  • APLS 4.4B
  • IPO Year
  • MAIN 2007
  • APLS 2017
  • Fundamental
  • Price
  • MAIN $52.14
  • APLS $26.27
  • Analyst Decision
  • MAIN Hold
  • APLS Buy
  • Analyst Count
  • MAIN 5
  • APLS 18
  • Target Price
  • MAIN $48.80
  • APLS $51.00
  • AVG Volume (30 Days)
  • MAIN 409.1K
  • APLS 3.5M
  • Earning Date
  • MAIN 11-07-2024
  • APLS 11-05-2024
  • Dividend Yield
  • MAIN 8.05%
  • APLS N/A
  • EPS Growth
  • MAIN 11.78
  • APLS N/A
  • EPS
  • MAIN 5.51
  • APLS N/A
  • Revenue
  • MAIN $529,897,000.00
  • APLS $715,216,000.00
  • Revenue This Year
  • MAIN $11.27
  • APLS $95.59
  • Revenue Next Year
  • MAIN $2.69
  • APLS $13.77
  • P/E Ratio
  • MAIN $9.47
  • APLS N/A
  • Revenue Growth
  • MAIN 9.27
  • APLS 162.10
  • 52 Week Low
  • MAIN $40.51
  • APLS $24.34
  • 52 Week High
  • MAIN $52.89
  • APLS $73.80
  • Technical
  • Relative Strength Index (RSI)
  • MAIN 58.04
  • APLS 36.30
  • Support Level
  • MAIN $51.80
  • APLS $24.34
  • Resistance Level
  • MAIN $52.89
  • APLS $29.94
  • Average True Range (ATR)
  • MAIN 0.75
  • APLS 1.66
  • MACD
  • MAIN 0.05
  • APLS 0.08
  • Stochastic Oscillator
  • MAIN 77.81
  • APLS 31.54

About MAIN Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing's, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: